A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors

NCT06376136 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

216

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors

Interventions

DRUG: BAT8010 for Injection
DRUG: BAT1006 for Injection

Sponsor

Bio-Thera Solutions